These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 26543085

  • 1. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
    Sugie S, Mukai S, Yamasaki K, Kamibeppu T, Tsukino H, Kamoto T.
    Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men.
    Sugie S, Mukai S, Tsukino H, Toda Y, Yamauchi T, Nishikata I, Kuroda Y, Morishita K, Kamoto T.
    Anticancer Res; 2013 May; 33(5):1893-7. PubMed ID: 23645736
    [Abstract] [Full Text] [Related]

  • 3. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y.
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
    Sagara Y, Mimori K, Yoshinaga K, Tanaka F, Nishida K, Ohno S, Inoue H, Mori M.
    Br J Cancer; 2004 Aug 31; 91(5):959-65. PubMed ID: 15305200
    [Abstract] [Full Text] [Related]

  • 5. Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.
    Sugie S, Mukai S, Yamasaki K, Kamibeppu T, Tsukino H, Kamoto T.
    Hum Cell; 2016 Jan 31; 29(1):22-9. PubMed ID: 26250899
    [Abstract] [Full Text] [Related]

  • 6. Simvastatin delays castration‑resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin‑1.
    Gao Y, Li L, Li T, Ma L, Yuan M, Sun W, Cheng HL, Niu L, Du Z, Quan Z, Fan Y, Fan J, Luo C, Wu X.
    Int J Oncol; 2019 Jun 31; 54(6):2054-2068. PubMed ID: 31081050
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer.
    Kamibeppu T, Yamasaki K, Nakahara K, Nagai T, Terada N, Tsukino H, Mukai S, Kamoto T.
    Res Rep Urol; 2018 Jun 31; 10():135-144. PubMed ID: 30324095
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M, Lee KH, Lee HS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C.
    Prostate; 2016 Feb 15; 76(3):273-85. PubMed ID: 26499308
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
    Wu F, Lin Y, Cui P, Li H, Zhang L, Sun Z, Huang S, Li S, Huang S, Zhao Q, Liu Q.
    Cancer Chemother Pharmacol; 2018 Jun 15; 81(6):999-1006. PubMed ID: 29605876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.